STARPHARMA FPO [SPL] (SPL.AX)
Develops dendrimer technology to deliver cancer drugs and antiviral treatments more effectively.
0.74-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+670.8%
The outlook
SPL is trading near its 52-week highs, well above both its 50- and 200-day moving averages. Analyst coverage appears limited, so sentiment data is thin. The current price sits comfortably in the upper portion of its yearly range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range93% of the way from its 52-week low to high
Market cap
$311.5M
52-wk high
0.79
52-wk low
0.09
50-day avg
0.70
200-day avg
0.51
Trailing P/E
—